Company: HUM
Filing Date: 2025-03-07
Form Type: DEF 14A
Source: 0001193125-25-048976
Chunk: 83

Company: HUMANA INC
Filing Date: 2025-03-07
Form: DEF 14A
Chunk 83
---
 the provision of similar services. The amount paid is not material to the Company and does not represent a direct or indirect material interest to Mr. Rechtin. |

| • |     | Wentworth Douglas Hospital. The Company had a business relationship with Wentworth Douglas Hospital, of which an immediate family member of our executive officer Sanjay K. Shetty, M.D. is employed. Wentworth Douglas Hospital is a provider in our network for which we paid approximately $7 million in medical claims during 2024, which is an amount that is comparable to non-affiliated providers for the provision of similar services. The amount paid is not material to the Company and does not represent a direct or indirect material interest to Dr. Shetty. |

| • |     | BlackRock, Inc. During 2024, the Company had an agreement with BlackRock, Inc., or BlackRock, which holds greater than five percent of the Company’s outstanding stock as of December 31, 2024. Under this agreement, BlackRock provided fixed income investment management services to the Company, for which the Company paid approximately $6.16 million in fees for the year ended December 31, 2024. The fees were determined solely on the amount of assets under management, and, to our knowledge, were comparable to those of non-affiliated customers. |

The Board of Directors has adopted a policy for review, approval and monitoring of transactions involving the Company and directors and executive officers or their immediate family members, or stockholders owning five percent or greater of the Company’s outstanding stock. The policy covers any related person transaction that meets the minimum threshold for disclosure under the SEC’s regulations. The Related Party Transaction Approval Policy may be viewed on our website. From the www.humana.comwebsite, click on “More Humana,” then click on “For Investors,” then click on “Corporate Governance,” and then click on the link titled “Policy Regarding Related Person Transactions.” Pursuant to that policy, our Board of Directors has approved the continuation for 2025 of the above-described relationships.

| 82 |     | Humana | 2025 Proxy Statement • Certain Transactions with Management and Others |

Audit Committee Report Our Audit Committee currently is comprised of four directors. All members are independent and are financially literate as defined in the NYSE listing standards. The Board of Directors has determined that Messrs. D’Amelio and Garratt and Dr. Bono each meet the definition of “audit committee financial expert.”